Co-Diagnostics, Inc. (CODX)
OTCMKTS · Delayed Price · Currency is USD
2.830
-0.090 (-3.08%)
At close: Jan 16, 2026
Co-Diagnostics Market Cap
Co-Diagnostics has a market cap or net worth of $5.74 million as of January 20, 2026. Its market cap has decreased by -76.01% in one year.
Market Cap
5.74M
Enterprise Value
-4.23M
Revenue
507.89K
Ranking
n/a
PE Ratio
n/a
Stock Price
$2.83
Market Cap Chart
Since July 12, 2017, Co-Diagnostics's market cap has decreased from 69.28M to 5.74M, a decrease of -91.71%. That is a compound annual growth rate of -25.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 5.74M | -44.05% |
| Dec 31, 2025 | 10.27M | -57.13% |
| Dec 31, 2024 | 23.95M | -41.12% |
| Dec 29, 2023 | 40.67M | -47.80% |
| Dec 30, 2022 | 77.91M | -70.08% |
| Dec 31, 2021 | 260.40M | -0.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jul 12, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 782.06M |
| Glass House Brands | 715.55M |
| Elite Pharmaceuticals | 505.65M |
| Northwest Biotherapeutics | 472.88M |
| Nika Pharmaceuticals | 395.06M |
| American Oncology Network | 386.20M |
| CytoDyn | 328.21M |
| Silence Therapeutics | 238.06M |